Rising Need for Organ Transplantation Fuels Europe Organ Preservation Solutions Market Growth
Organ transplantation is a surgical procedure used when a patient's organ no longer functions properly. Heart, liver, and kidney transplantation are the most performed organ transplantation procedures. However, the rising prevalence of chronic diseases is necessitating organ transplantation for organs such as lungs, pancreas, cornea, and vascular tissues. Organ transplantation is regarded as one of the most significant advances in modern medicine.The rise in chronic diseases that cause damage to the functions of the heart, lungs, liver, kidney, and other organs is leading to an increase in the number of organ transplants. Moreover, excessive alcohol consumption leads to liver cirrhosis, ultimately resulting in a liver transplant. A poor diet contributes to the development of renal and hepatic illnesses, which can lead to organ failure. This is another factor contributing to the growth of organ transplantation and, therefore, the preservation solutions market. Transplantation surgeries are becoming more common worldwide. For instance, in Spain, the Organizacion Nacional de Transplantes (ONT) manages the program, where growth in donations has been significant, from 14.3 per million population in 1980 to 49 deceased donors per million population in 2019, i.e., an increase to 2,302 donors in 2019. Furthermore, as per the ONT, a 40% increase in donors has been observed from 2016 to 2021. By adopting a “50-22” directive, the goal was to reach 50 donors per million population by 2022.
The public-private partnership, in collaboration with transplant coordinators, has made a significant contribution to the improvement of organ transplantation. Both developing and developed countries have seen an increase in the number of organ transplant surgeries.
Europe Organ Preservation Solutions Market Overview
The market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The market is driven by the factors such as increasing government, innovative technology and products, and growing prevalence of chronic diseases in the region.Germany is an attractive market due to its consistent growth and innovative approach toward the healthcare sector. According to Federal Statistical Office, health expenditure in Germany amounted to US$ 474 billion in 2021. The demand for highly innovative technologies and diagnostic, therapeutic, and minimally invasive equipment remains high worldwide.
Rising geriatric population and increasing prevalence of chronic diseases are expected to propel market growth. With the growing age, many organs start to malfunction or become dysfunctional giving rise to organ transplantation procedures. For instance, according to the WHO, in Germany, 34% of people aged 65 and above reported having one chronic disease, and 24% of people aged 65 and above reported having two chronic diseases.
In addition, public health issues resulting in chronic health disorders also give rise to organ transplantation procedures. For instance, according to the WHO, about four in ten deaths in Germany result from behavioral risk factors, including dietary risks, smoking, alcohol consumption, and low physical activity. In 2021, ~19% of adults were obese in Germany. Obesity gives rise to various other health-related problems.
Europe Organ Preservation Solution Market Revenue and Forecast to 2028 (US$ Million)
Europe Organ Preservation Solution Market Segmentation
The Europe organ preservation solution market is segmented into type, application, organ type, end user, and country.Based on type, the Europe organ preservation solution market is segmented into university of wisconsin solution, custodiol htk, perfadex, hypothermosol, and others. The university of wisconsin solution segment registered the largest Europe organ preservation solution market share in 2023.
Based on application, the Europe organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest Europe organ preservation solution market share in 2023.
Based on organ type, the Europe organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held the largest Europe organ preservation solution market share in 2023.
Based on end user, the Europe organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics, The organ transplant centers segment held the largest Europe organ preservation solution market share in 2023.
Based on country, the Europe organ preservation solutions market has been categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe organ preservation solutions market share in 2023.
Accord Healthcare; Dr. Franz Koehler Chemie GmbH; Lifeline Scientific, Inc; OrganOx Limited; Paragonix Technologies, Inc; and TransMedics are the leading companies operating in the Europe organ preservation solutions market in the region.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe organ preservation solution market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe organ preservation solution market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the organ preservation solution market as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table of Contents
Companies Mentioned
- Accord Healthcare
- Dr. Franz Koehler Chemie GmbH
- Lifeline Scientific, Inc
- OrganOx Limited
- Paragonix Technologies, Inc
- TransMedics
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 139 |
Published | August 2023 |
Forecast Period | 2023 - 2028 |
Estimated Market Value in 2023 | 69.9 Million |
Forecasted Market Value by 2028 | 99.51 Million |
Compound Annual Growth Rate | 7.3% |
Regions Covered | Europe, United States |
No. of Companies Mentioned | 6 |